U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07860957) titled 'Midday Bright Light Therapy for Bipolar Depression' on Oct. 01.
Brief Summary: This randomized, double-blind, placebo-controlled study evaluated the efficacy of bright light therapy as an add-on treatment for adults with bipolar I or bipolar II disorder experiencing a mild-to-moderate depressive episode. The study examined whether bright light therapy improves depressive symptoms and also evaluated its effects on clinical status, psychosocial functioning, sleep quality, circadian characteristics, and treatment-emergent adverse effects.
Participants continued their existing mood stabilizer and/or atypical antipsychotic treatment at u...